We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody

    Regulatory T cells (Tregs) are known to facilitate tumor progression by suppressing CD8+ T cells within the tumor microenvironment (TME), thereby...

    Helge G. Roider, Sabine Hoff, ... Mátyás Gorjánácz in Clinical and Experimental Medicine
    Article Open access 10 June 2024
  2. Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients

    Background

    MCL-1 is a prosurvival B-cell lymphoma 2 family protein that plays a critical role in tumor maintenance and survival and can act as a...

    Junichiro Yuda, Christine Will, ... Andrew J. Souers in Communications Medicine
    Article Open access 25 October 2023
  3. A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies

    Tumor-selective viruses are a novel therapeutic approach for treating cancer. Tumor-Specific Immuno Gene Therapy (T-SIGn) vectors are tumor-selective...

    Danny N. Khalil, Isabel Prieto González-Albo, ... Gerald A. Soff in Investigational New Drugs
    Article 10 March 2023
  4. Selumetinib: a selective MEK1 inhibitor for solid tumor treatment

    Cancer incidence is rapidly growing. Solid tumors are responsible for a majority of cancers. Recently, molecular-targeted agents have played a...

    Mohaddeseh Hedayat, Reza Jafari, Naime Majidi Zolbanin in Clinical and Experimental Medicine
    Article 16 February 2022
  5. Selective targeting or reprogramming of intra-tumoral Tregs

    Regulatory T cells (Tregs) are critical immunosuppressive cells that are frequently present in the tumor microenvironment of solid cancers and enable...

    Keywan Mortezaee in Medical Oncology
    Article 11 February 2024
  6. Artemisia vulgaris Induces Tumor-Selective Ferroptosis and Necroptosis via Lysosomal Ca2+ Signaling

    Objective

    To evaluate the chemical composition and effects of Artemisia vulgaris (AV) hydroalcoholic extract (HEAV) on breast cancer cells (MCF-7 and...

    Lucas dos Santos Zamarioli, Michele Rosana Maia Santos, ... Claudia Bincoletto in Chinese Journal of Integrative Medicine
    Article 02 December 2023
  7. The role of tumor-associated macrophages in tumor immune evasion

    Background

    Tumor growth is closely linked to the activities of various cells in the tumor microenvironment (TME), particularly immune cells. During...

    Ruizhe Huang, Ting Kang, Siyu Chen in Journal of Cancer Research and Clinical Oncology
    Article Open access 07 May 2024
  8. Targeting the IRE1α-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling

    Liver-specific Ern1 knockout impairs tumor progression in mouse models of hepatocellular carcinoma (HCC). However, the mechanistic role of IRE1α in...

    Tingting Zhang, Faming Zhao, ... **a Sheng in Oncogene
    Article 28 February 2024
  9. Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA) to Improve Tumor Visualization, Navigation and Margin Confirmation in Percutaneous Liver Tumor Ablation

    Purpose

    We present a technique that combines Hepatic Arteriography with C-arm CT-Guided Ablation (HepACAGA) to improve tumor visualization, navigation...

    Maarten L. J. Smits, Rutger C. G. Bruijnen, ... Warner Prevoo in CardioVascular and Interventional Radiology
    Article Open access 13 September 2023
  10. Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity

    Interleukin-12 (IL-12) can be used as an immunomodulator in cancer immunotherapy. And it has demonstrated enormous potential in inhibiting tumor...

    Yulian Xu, Xueli Sun, Yunguang Tong in Discover Oncology
    Article Open access 16 May 2024
  11. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

    Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite...

    Shaosen Zhang, **nyi **ao, ... Chen Wu in Signal Transduction and Targeted Therapy
    Article Open access 19 June 2024
  12. Tumor biomarkers for diagnosis, prognosis and targeted therapy

    Tumor biomarkers, the substances which are produced by tumors or the body’s responses to tumors during tumorigenesis and progression, have been...

    Yue Zhou, Lei Tao, ... Yinglan Zhao in Signal Transduction and Targeted Therapy
    Article Open access 20 May 2024
  13. Laparoscopic Anatomical Cranial Sub-segmentectomy of Segment VII (S7) with Super-Selective Intra-arterial Nano-ICG Positive Staining-Guided Trans-Parenchymal Approach

    Background

    With introduction of “cone unit,” which is the smallest resectable anatomical area supplied by a tertiary branch of Glissonean pedicle,...

    Ziqi Hou, Guoteng Qiu, ... Jiwei Huang in Annals of Surgical Oncology
    Article 22 April 2024
  14. Effect of an Airbag-selective Portal Vein Blood Arrester on the Liver after Hepatectomy: A New Technique for Selective Clam** of the Portal Vein

    Objective

    A novel technique was explored using an airbag-selective portal vein blood arrester that circumvents the need for an intraoperative...

    Ce-xiong Fu, **ao-ri Qin, ... **-fang Zheng in Current Medical Science
    Article 22 March 2024
  15. Unexpected anti-tumor effect of immune checkpoint inhibitors followed by transcatheter arterial chemoembolization for hepatocellular carcinoma

    The abscopal effect has recently attracted much attention because this effect is enhanced by immune checkpoint inhibitors (ICIs). However, little is...

    Yoshiaki Ando, Azusa Sakamoto, Hiroyuki Marusawa in Clinical Journal of Gastroenterology
    Article 28 September 2023
  16. Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma

    Background & aims

    Patients with intrahepatic cholangiocarcinoma (iCCA) respond poorly to immune checkpoint blockades (ICBs). In this study, we aimed...

    Bao-Ye Sun, Dai Zhang, ... Shuang-Jian Qiu in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  17. Synthesis and evaluation of [18F]FBNAF, a STAT3-targeting probe, for PET imaging of tumor microenvironment

    Background

    Signal transducer and activator of transcription 3 (STAT3) is a protein that regulates cell proliferation and differentiation, and it is...

    Anna Miyazaki, Yasukazu Kanai, ... Takashi Temma in EJNMMI Radiopharmacy and Chemistry
    Article Open access 04 June 2024
  18. Involvement of inflammasomes in tumor microenvironment and tumor therapies

    Inflammasomes are macromolecular platforms formed in response to damage-associated molecular patterns (DAMPs) and pathogen-associated molecular...

    Ziqi Zhang, Xue Li, ... **awei Wei in Journal of Hematology & Oncology
    Article Open access 17 March 2023
  19. Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome

    Introduction

    Tumor-induced osteomalacia (TIO) is an uncommon paraneoplastic syndrome due to the overproduction of fibroblast growth factor 23 (FGF23)....

    Luciano Colangelo, Chiara Sonato, ... Salvatore Minisola in Archives of Osteoporosis
    Article Open access 12 July 2023
  20. Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks

    Mortalin (encoded by HSPA9 ) is a mitochondrial chaperone often overexpressed in cancer through as-yet-unknown mechanisms. By searching different...

    Wen**g Chen, Young Shin Song, ... Jong-In Park in Oncogene
    Article 27 June 2024
Did you find what you were looking for? Share feedback.